Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccines

Int J Dermatol. 2022 Jul;61(7):900-902. doi: 10.1111/ijd.16296. Epub 2022 May 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • ChAdOx1 nCoV-19
  • Humans
  • Lymphomatoid Papulosis* / diagnosis
  • Skin Neoplasms*

Substances

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19
  • BNT162 Vaccine